Physician profile
Daniel V Wang
NPI 1982967923
$2,305.81
in general payments reported to CMS, 2019-2025
7 companies · $781 in 2025
The $781 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.98 · 2020: $92.62 · 2021: $26.95 · 2022: $170 · 2023: $795 · 2024: $428 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,004.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,004.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $1,360.73 | 2022-2025 | Carto 3, Nuvision Ice Catheter, Qdot Micro Catheter |
| Janssen Pharmaceuticals, INC | $646.81 | 2023-2024 | Xarelto |
| Abbvie INC. | $142.74 | 2021-2022 | |
| Bioventus LLC | $81.10 | 2020 | |
| United Therapeutics Corporation | $34.30 | 2022-2023 | Tyvaso, Orenitram |
| Allergan, INC. | $23.50 | 2019-2020 | |
| Ethicon US, LLC | $16.63 | 2024 | Stratafix, Ethicon, Vistaseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.